Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has provided an update.
Proteomics International Laboratories Ltd announced the cessation of 4,102 employee performance rights due to unmet conditions as of June 30, 2025. This development may affect the company’s employee incentive plans and reflects the challenges in meeting performance targets, which could have implications for its operational strategies and stakeholder confidence.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests and analytical services. The company is known for its expertise in proteomics, which involves the large-scale study of proteins, particularly their structures and functions.
Average Trading Volume: 247,143
Technical Sentiment Signal: Sell
Current Market Cap: A$69.5M
For detailed information about PIQ stock, go to TipRanks’ Stock Analysis page.